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Cross-Priming Ampliﬁcation (CPA) has been shown to rapidly and effectively detect Mycobacterium
tuberculosis (MTB) in sputum samples under isothermal conditions. However, no performance data exist
from peripheral-level tuberculosis (TB) clinics in tuberculosis-endemic countries. We conducted a clinical
trial at four county-level TB clinics in China to evaluate the effectiveness of the CPA assay. TB suspects
were continuously enrolled by a clinician at each clinic. Following informed consent, each patient pro-
vided two sputum specimens (spot and morning sputum). Sputum samples were tested by smear mi-
croscopy, solid culture and CPA. The National TB reference laboratory (NTRL) collected all culture positive
strains and performed 16Se23S rDNA internal transcribed spacer (ITS) sequence analysis for strain
identiﬁcation. Solid culture was used as the gold standard to evaluate the effectiveness of CPA in
detecting MTB. A total of 2200 TB-suspected patients were enrolled at the four county-level TB clinics.
Compared to solid culture, the sensitivity and speciﬁcity of the CPA test for MTB detection within this
group was 84.1% (95%CI, 79.5e88.6) and 97.8% (95%CI, 97.1e98.5), respectively, and the sensitivity in
smear-negative cases was 59.8% (95%CI, 49.8e69.8). The test failure rate of CPA was 0.8% (32/3918),
signiﬁcantly lower than the 1.7% (106/6138) culture contamination rate.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
China has the second largest TB-burden in the world, with
nearly 200,000 TB-related deaths per year [1]. TB diagnostics
commonly used in Chinese TB labs are associated with a number of
issues. Smear microscopy, although inexpensive, has a relatively
low sensitivity, and therefore only diagnoses patients with rela-
tively advanced disease [2]. While solid culture has a high sensi-
tivity, it requires a turnaround time of 3e8 weeks [3]. Recently, a
number of nucleic acid ampliﬁcation technologies have been
developed for the rapid diagnosis of MTB. Many are more sensitive
than smear microscopy and demonstrate substantial advantages
over conventional culture [4,5]. However, many commercialized
nucleic acid tests have not found wide-spread use due to a numbertrol and Prevention, Chinese
2206, China.
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Ltd. This is an open access article uof remaining issues. This includes the use of complicated meth-
odologies, the need for high-cost, high-precision equipment and
disposables, and the need for highly-skilled lab technicians and
associated technical support [6e8]. These tests are therefore un-
suitable for use in most high TB-burden and resource-limited
settings.
Cross-Priming Ampliﬁcation (CPA) is a new nucleic acid ampli-
ﬁcation technique for the detection of TB and other diseases
developed by Ustar Biotechnologies Co., Ltd China. Using multiple
cross-linked primers, CPA can amplify a target nucleic acid under
isothermal conditions without the need for any specialized equip-
ment. The CPA testing kit for TB detection includes sample prepa-
ration (60 min), nucleic acid isothermal ampliﬁcation (60 min), and
hybridization and detection using a patented cross-contamination
proof device (20 min) [9e11]. The detection of ampliﬁed products
is performed on a lateral ﬂow strip housed in an enclosed, sealed
plastic device to prevent the leakage of amplicons.
A previous report demonstrated excellent performance of the
CPA test kit at a reference laboratory [12]. In this previous study,
two cross primers (double crossing CPA) targeting the gyrB gene
were used to detect MTB in clinical samples. The CPA test detectednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Figure 1. Process illustration for the CPA cartridge.
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with smear-negative disease. Here we evaluate an optimized CPA
reaction that utilizes only one cross primer (single crossing CPA)
targeting the IS6110 region of the MTB genome and is multiplexed
with an internal ampliﬁcation control reaction. As the estimated
cost of CPA is 4$e5$ per test, it is suitable to be used in resource-
limited settings. Our goal was to evaluate the performance of the
single crossing CPA test for TB diagnosis at four peripheral labs in
China and to explore its potential use as a screening tool at mi-
croscopy labs throughout China.
2. Methods
2.1. Study design
During January, 2012, NTRL staff provided a week-long training
on solid culture and CPA test for the staff members from four
county-level clinics in Zhengding County, Changqing County, Xinmi
District, and Changping District. Lab technicians were required to
take a proﬁciency test and only those who passed the test were
allowed to participate in this study. A pilot study on the use of CPA
was conducted and supervised by the NTRL at each local site for 1
month at which point performance was veriﬁed. FromMarch, 2012
to October, 2012, the four county-level TB clinics enrolled patients
suspected of having TB based on their clinical symptoms; and
following informed consent, collected 2 sputum samples (spot
sputum and morning sputum). Lab technicians tested each sputum
sample using smear microscopy, solid culture and CPA tests. A pa-
tient was deemed positive if one sample tested positive.
NTRL staff collected all culture positive samples and performed
16Se23S rDNA internal transcribed spacer sequence analysis. Pos-
itive specimens with culture results that were contaminated, had
no strain identiﬁcation results or were non-TB were excluded from
ﬁnal analysis. The remaining samples were used to evaluate the
performance of the CPA test in detecting MTB compared to solid
culture among new TB suspects. We assessed the operational
feasibility of the CPA test by examining indicators such as test
failure rate, turnaround time and the variation of performance
between sites. We also administered a user-acceptability ques-
tionnaire to establish theminimal training needs and ease of use for
the CPA test.
2.2. Procedures
2.2.1. Smear microscopy
Smear microscopy was performed in accordance with the China
NTPdSputum Smear SOP and Quality Assurance Manual [13].
2.2.2. Solid culture
2ml of sputum sample was transferred into a sealable tube with
a screw cap. Depending on the viscosity of sample, 1e2 volumes of
4% sodium hydroxide pretreatment solution was added, and the
sample was then vortexed for 30e60 s until it was fully mixed after
which it was left to stand for 15 min. The solution (0.1 ml) was
inoculated into two LowensteineJensen Medium slants, which
were then incubated for 24 h at 37 C in a standing position and
then cultivated further at 37 C. Bacilli growth was monitored and
recorded at Day 3 and Day 7, and then every week until the 8th
week.
2.2.3. CPA
Sputum was mixed with 2e3 volumes of 4% sodium hydroxide
solution and allowed to stand for 20e30 min at room temperature
until fully liqueﬁed. One ml of liqueﬁed sputum was transferred
into a 1.5 ml centrifuge tube and centrifuged at 10,000 rpm for10 min. The pellet was suspended in 1 ml of physiological saline
(0.9% w/v NaCl) and washed two times by centrifugation under the
above mentioned protocol. The liquiﬁcation and centrifugation for
sample processing was performed in a bio-safety cabinet. An
aliquot of 40 mL of a DNA extraction solution (Ustar) was transferred
into the centrifuge tube containing the pellet, the tube was then
placed in a boiling water bath (95e100 C) for 10 min, and then
removed and allowed to cool to room temperature. The tube was
centrifuged at 10,000 rpm for 5 min and the supernatant was saved
as the ampliﬁcation template. 15 mL of re-suspension buffer was
added to each ampliﬁcation tube containing Ustar’s proprietary
glassiﬁed reagents followed by 20 mL of parafﬁn oil [14e16]. Tubes
were allowed to incubate at room temperature for 2e3 min to
allow the glassiﬁed reagents to dissolve completely. For the nega-
tive and positive controls 4 mL ddH2O or supplied positive control
was added to a reconstituted assay tube and 4 mL of each extracted
sample was added to the remaining tubes. All reaction tubes were
centrifuged again at 4000 rpm for 3e5 s before being placed on a
heat block at 63 C for 60min. Following ampliﬁcation, the reaction
tubes were placed into the cartridge of the detection device, which
was folded to close and then inserted into the device. The handle
was closed shut to lock producing a clear “click” sound. After 15e
30 min the lateral ﬂow strip results were read by visual inspection
from within the device (Figure 1). Results were determined by
observing the presence or absence of a test and control line which
indicate the ampliﬁcation of TB DNA and internal control DNA
respectively. When both test and control lines were present the
sample was deemed positive. When only the control line was
present the sample was deemed negative. When the control line
was not observed the sample was deemed invalid, the kit maybe
damaged, incorrect operation or expired. Signal intensity of the test
line was compared to an intensity score-card provided by the
manufacturer.
2.2.4. 16Se23S rDNA ITS sequence
In order to identify MTB and Non-tuberculousis Mycobacterium
(NTM) [17], 16Se23S rDNA ITS sequence analysis was performed
using a forward primer, 50-GGCCTAACCCTCGGGAGGGAG-30, and
reverse primer 50-CCCGAGGCATATCGCAGCCTC-30. Primers were
synthesized by Sangon Biotech (Shanghai) Co., Ltd. Direct
sequencing was performed on the ABI 3730 DNA automated
sequence analyzer. Sequence results were uploaded to the NCBI
website for blast analysis.
Table 2
The correlation between smear and culture results.
Smear Culture
NEG Scanty 1þ 2þ 3þ 4þ Total
X. Ou et al. / Tuberculosis 94 (2014) 428e4334302.3. Statistical analysis
Results were analyzed using SPSS 17.0 software. 95% conﬁdence
intervals (CI) were calculated according to method described by
Robert Newcombe [18].NEG 1889 53 38 17 10 9 2016
Scanty 1 1 2 1 1 1 7
1þ 4 3 1 5 10 9 32
2þ 2 1 3 15 11 14 46
3þ 1 0 1 5 18 20 45
4þ 1 1 0 0 9 37 48
Total 1898 59 45 43 59 90 2194
Notes: NEG ¼ Negative.2.4. Ethics statement
The study was approved by the Tuberculosis Research Ethics
Review Committee of the China CDC. Written informed consent
was obtained from each participant. All the authors vouch for the
completeness and accuracy of the data presented.Table 3
The correlation between smear and CPA results.
Smear CPA Total
NEG POS
NEG 1924 95 2019
Scanty 1 6 7
1þ 3 29 32
2þ 3 43 46
3þ 3 42 45
4þ 2 46 48
Total 1936 261 2197
Notes: POS ¼ Positive. NEG ¼ Negative.3. Results
3.1. Smear, culture and CPA test results
From March, 2012 to October, 2012, a total of 2200 TB suspects
were enrolled from the four TB clinics. Two cases had no smear
results, four had contaminated culture result and one case gener-
ated an invalid CPA result. The smear positive rate was 8.1% (178/
2198), the culture positive rate was 13.5% (296/2196) and the CPA
positive rate was 11.9% (261/2199) (Table 1).
Correlation analysis between smear and culture results was
performed on 2194 cases, excluding the 2 cases with no smear
results and 4 cases with culture contamination. Among seven pa-
tients with scanty smear positive results, 6 were culture positive;
and an additional 8 patients had smear positive (1þ) results but
were culture negative. Statistical analysis demonstrated that
sputum smear positivity was signiﬁcantly correlated with culture
positivity (p < 0.01) (Table 2).
Among the 2197 cases with valid sputum smear and CPA results,
sputum smear positivity was not related to CPA detection rates for
MTB (p > 0.05). Of the 2019 smear-negative samples, 95 were CPA
positive; and of the 7 smear scanty positive samples, 6 were CPA
positive (Table 3).3.2. Results of 16Se23S rDNA ITS sequence analysis for culture
positive strains
16Se23S ITS sequence analysis was performed for 296 culture
positive samples. 28 samples reported no sequencing results, 64%
(18/28) samples recorded less than 10 cultured colonies. Of the 268
samples with successful sequencing results, 94.4% (253/268) were
identiﬁed as MTB, 0.4% (1/268) identiﬁed as Nocardia and 5.2% (14/
268) were identiﬁed as other NTMs.
Among the 14 NTM infected patients, 5 were smear positive, and
2 were CPA positive. The 2 CPA positive cases were infected with
Mycobacterium intracellulare and were both culture and smear
positive.Table 1
Compiled results from smear, culture and CPA for 2200 recruited patients.
Smear Culture
POS NEG No result Total POS N
Zhengding 39 449 0 488 72
Changqing 34 448 2 484 41
Xinmi 60 624 0 684 92
Changping 45 499 0 544 91
Total 178 2020 2 2200 296 1
Notes: POS ¼ Positive. NEG ¼ Negative. CON ¼ Contamination.3.3. Quality control of solid culture and CPA assay
A total of 4402 sputum samples were cultured in 4 labs. Of the
8804 culture media tubes, 110 were contaminated, for a total
contamination rate of 1.25%. This was within the SOP requirement
of 5%. The culture contamination rate of each lab was also within
normal ranges. A total of 178 smear positive patients were enrolled,
of which 9 were culture negative, the smear positive culture
negative rate was 5.1%, which was below the SOP requirement of
10%. CPA tests were performed on 3918 sputum samples, among
which 32 test failures were observed, with a failure rate of 0.8%
(Table 4).3.4. Effectiveness analysis of CPA assay compared to solid culture as
the gold standard
Of the 2200 new TB suspects enrolled by the four TB clinics,
2150 cases were eligible for CPA effectiveness analysis. Of the 2150
cases, 251 were culture positive and 1899 were culture negative
(Figure 2).
Within this group of cases, the sensitivity and speciﬁcity of the
CPA test for detecting MTB compared to solid culturewas 84.1% and
97.8%, respectively. No signiﬁcant difference was observed for the
sensitivity of the CPA test among the four labs (P > 0.05); while
signiﬁcant differences were observed in speciﬁcity (P < 0.01).CPA
EG CON Total POS NEG Failure Total
413 3 488 62 426 0 488
442 1 484 35 449 0 484
592 0 684 79 604 1 684
453 0 544 85 459 0 544
900 4 2200 261 1938 1 2200
Table 4
IQC of culture and CPA at four sites.
Cases The rate of smear
positive culture
negative
Culture
contamination
rate
CPA
failure
rate
Zhengding 488 5.1% 3.3% 2.7%
Changqing 484 2.9% 2.0% 0.0%
Xinmi 684 6.7% 0.1% 0.4%
Changping 544 4.4% 0.3% 0.0%
Total 2200 5.1% 1.3% 0.8%
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speciﬁcity of CPA test was 59.8% and 98.0% for detecting MTB
(Table 5). No statistically signiﬁcant difference was observed for the
sensitivity of the CPA test among the four labs (P > 0.05), while
signiﬁcant differences were found in speciﬁcity (P< 0.01) (Table 5).
3.5. Analysis of cases whose culture result was inconsistent with the
CPA result
Among the 42 culture negative but CPA positive cases, 4 were
smear positive and clinically diagnosed with TB, 24were smear and
culture negative but clinically diagnosed with TB, and 14 were
smear, culture and clinically negative for TB.
Among the 40 culture positive CPA negative cases, 38 were
smear-negative, and 21 had a colony number of less than 10 (53%).
3.6. Comparison of turnaround time
After collecting sputum samples, the four labs conducted smear
microscopy, solid culture and CPA tests on the same day. Samples
that were not tested were stored at 20 C and tested the next day.
During the study, the average turnaround time of the CPA test
(starting from sample treatment to test results read-out) was
around 3 h, while that of solid culture was 52.5 days (56 days
maximum and 7 days minimum).
3.7. Analysis of acceptability of the CPA test among lab technicians
Six laboratory operators completed a questionnaire on the
acceptability of the CPA test. According to the survey, 5 (83%)
believed that the CPA procedure was easier to learn and perform, 3
(50%) believed the quality control of the CPA test was equivalent to
that of solid culture, 2 (33%) believed the CPA test results weremore
reliable compared to solid culture, 6 (100%) believed CPA had a
lower failure rate compared to solid culture, 3 (50%) believed that aFigure 2. Case enrollment and test procedure.longer manual operationwas required by solid culture compared to
CPA and all believed that solid culture was associated with higher
risks for lab technicians.
4. Discussion
Early diagnosis is of vital signiﬁcance to TB control. This study
selected four county-level TB clinics and enrolled new TB suspects
to explore the applicability and feasibility of the CPA test. The
selected study sites routinely perform sputum smear microscopy
for TB diagnosis and have not previously performed any molecular
diagnostic testing. However, solid culture was previously per-
formed for a research project for The Nation Survey of Drug-
Resistant Tuberculosis and the labs were renovated in accordance
with bio-safety requirements. Additionally a one month solid cul-
ture trial period was conducted prior to our study to ensure the
quality of solid culture.
The results of this study demonstrate that CPA provided an easy
to read TB result that signiﬁcantly reduced the reporting time
compared with solid culture. We further demonstrated that CPA
can be performed by lab technicians with no prior molecular
testing experience, following a short training period.
Positivity grades of smear and culture results are effective in-
dicators of the amount of MTB. Smear and culture positivity grades
were correlated in this study and it was hypothesized that smear
positivity would correlate with CPA detection rates, with lower
detection rates found at lower grades of smear positivity. However,
our analysis found no correlation between the CPA positive detec-
tion rates and smear positivity. This is likely due to the high
sensitivity of the CPA assay compared to microscopy as CPA is able
to amplify as little as 4 copies of genomic DNA in less than an hour
with a high degree of speciﬁcity.
Among the 14 cases with NTM infection, 2 infected with M.
intracellularewere CPA positive. This may have been due toMTB co-
infection (not conﬁrmed) or to a lack of speciﬁcity of the CPA
primers. The sensitivity and speciﬁcity of CPA for detecting MTB
was 84.1% and 97.8%, lower than the 92.8% and 98.8% sensitivity and
speciﬁcity reported by a previous study performed at a reference
laboratory [12]. This may be explained by the modiﬁed CPA assay
used in this study, which included an internal ampliﬁcation control,
or by differences in testing facilities and patient populations found
at each research site. Among smear-negative patients, CPA was
59.8% sensitive and 98.0% speciﬁc for detecting MTB, demon-
strating an improved diagnostic effectiveness among smear-nega-
tive patients in the absence of culture. Among the 42 culture
negative but CPA positive patients, 14 were clinically diagnosed
non-TB. These false positives may have been due to contamination
during ampliﬁcation or the presence of killed bacteria. Among the
40 culture positive but CPA negative patients, 21 (53%) scored a
colony number of less than 10, suggesting that following sample
preparation, some samples were below the CPA detection limit.
Inhibitor of CPA such as hemoglobin in bloody sputum samplesmay
have also been a problem, although theoretically the internal
ampliﬁcation control should have controlled for this.
Effectiveness indicators for the CPA test in the four labs were
generally comparable, however, due to variations in lab capacity
and skill levels, some differences were observed in the perfor-
mance. We found no signiﬁcant difference in the sensitivity of the
CPA test among the four labs, but observed signiﬁcant differences in
speciﬁcity. The positive predictive values of Changping and
Zhengding were 76.3% and 77.1%, respectively, lower than the other
two sites. Operation bias, leading to contamination or nonspeciﬁc
ampliﬁcation may have contributed to these lower values. The
performance of solid culture, which was used as the gold standard
for this research, may have also affected the evaluation of the CPA
Table 5
Sensitivity and speciﬁcity of the CPA test from TB suspects, as compared with solid culture and strain identiﬁcation.
CPA Culture Sub-total Sensitivity (95%CI) Speciﬁcity (95%CI) PPV (95%CI) NPV (95%CI)
POS NEG Cþ (95%CI) S-Cþ (95%CI)
Zhengding POS 45 14 59 84.9% (75.3e94.5) 55.6% (32.6e78.5) 96.6% (94.9e98.4) 76.3% (65.4e87.1) 98% (96.7e99.4)
NEG 8 399 407
Sub-total 53 413 466
Changqing POS 34 0 34 89.5% (79.7e99.2) 57.1% (20.5e93.8) 100% (99.3e100) 100% (39.8e100) 99.1% (98.2e99.9)
NEG 4 440 444
Sub-total 38 440 478
Xinmi POS 68 9 77 87.2% (79.8e94.6) 61.5% (42.8e80.2) 98.5% (97.5e99.5) 88.3% (81.1e95.5) 98.3% (97.3e99.4)
NEG 10 584 594
Sub-total 78 593 671
Changping POS 64 19 83 78.1% (69.1e87.0) 61% (46.0e75.9) 95.8% (94.0e97.7) 77.1% (68.1e86.2) 96% (94.2e97.8)
NEG 18 434 452
Sub-total 82 453 535
Total POS 211 42 253 84.1% (79.5e88.6) 59.8% (49.8e69.8) 97.8% (97.1e98.5) 83.4% (78.8e88.0) 97.9% (97.2e98.5)
NEG 40 1857 1897
Sub-total 251 1899 2150
Notes: POS ¼ Positive. NEG ¼ Negative. PPV ¼ Positive predictive value. NPV ¼ Negative predictive value.
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Xinmi and Changping, potentially due to harsh specimen decon-
tamination procedures. This may have decreased the sensitivity of
solid culture which can only detect live bacteria. Given equal
sensitivity and speciﬁcity, lower prevalence leads to lower positive
predictive values. A sensitivity and speciﬁcity of 83.7% and 97.9%,
and an assumed 25% prevalence, gives a positive predictive value of
93%. Given the accuracy of the CPA test and the importance of
preventing patient injury due to false positives we suggest that the
CPA test should be recommended for use in populations with a TB
prevalence above 25%.
The LAMP TB test kit by Eiken Chemical Co., Ltd. is another
promising isothermal ampliﬁcation diagnostic for TB [19,20]. The
ﬁrst generation of this test displayed a sensitivity of 48.8% in smear-
negative culture positive specimens, lower than the CPA sensitivity
we report here [21]. However, the second generation PURE-LAMP
kit has a reported sensitivity of 55.6% among smear-negative TB
patients, similar to our CPA results. Although further imple-
mentation data is needed to fully assess this method, the PURE-
LAMP kit requires fewer procedures and consumables than CPA,
and the entire process from sputum sample treatment to ampliﬁ-
cation reaction and result read-out is all performed in three closed
plastic devices, greatly reducing the risks of contamination. In
comparison the CPA sputum processing method was fairly
complicated requiring centrifugation, multiple pipetting steps and
the requirement for a biological safety cabinet. Currently, Ustar is
working to improve sputum sample processing and DNA extraction
in order to increase sensitivity among smear-negative patients as
well as usability in peripheral-level clinics. One advantage of the
CPA test kit is the ability to ship all reagents at room temperature.
This is achieved by a proprietary glass-transition process, devel-
oped by Ustar that glassiﬁes the enzymes providing long-term
stability at a wide range of temperatures [14e16].
In conclusion, the CPA test is a rapid, direct and reliable new
diagnostic for TB detection. Through this feasibility evaluation of
the CPA test, we found that this technology is well suited for use in
China’s microscopy labs for the screening of TB patients.
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